Keyphrases
Tumor
82%
COVID-19
61%
Adverse Events
53%
Gemcitabine
47%
Overall Survival
43%
Pancreatic Cancer
37%
Klebsiella Pneumoniae (K. pneumoniae)
35%
Glioma
34%
COVID-19 Vaccine
33%
Esophagectomy
33%
Radiosensitization
32%
Durvalumab
31%
Stage III Non-small Cell Lung Cancer
31%
Inflammation
30%
Circulating Tumor Cells
30%
Fitness Factor
29%
Checkpoint Kinase 1 (CHK1)
28%
High Risk
28%
Pancreatic Cancer Cells
27%
Non-small Cell Lung Cancer (NSCLC)
26%
Progression-free Survival
26%
Confidence Interval
26%
Poor Prognosis
25%
Lung Adenocarcinoma
25%
Hospitalized Patients
25%
Amyotrophic Lateral Sclerosis
24%
Immunohistochemistry
24%
Vaccine Adverse Event Reporting System (VAERS)
24%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
23%
In Cancer
23%
Homologous Recombination Repair
23%
Effector T Cells
22%
11-oxygenated Androgens
22%
Esophageal Cancer
22%
Targeted Therapy
22%
Enhancer of Zeste Homolog 2 (EZH2)
21%
Programmed Death-ligand 1 (PD-L1)
21%
Phase II Study
21%
T Cells
20%
Vaccine Adverse Events
20%
Survival Analysis
20%
Excision
20%
AZD7762
20%
Michigan
19%
Type 1 Diabetes Mellitus (T1DM)
19%
Prognostic Value
19%
Tumor Immunity
19%
Pathologist
18%
Myeloid-derived Suppressor Cells
18%
21-Hydroxylase Deficiency (21OHD)
18%
Medicine and Dentistry
Neoplasm
100%
Biological Marker
72%
COVID-19
58%
Ganglioglioma
53%
Esophagectomy
45%
Non Small Cell Lung Cancer
44%
Overall Survival
39%
Diseases
39%
Malignant Neoplasm
37%
Melanoma
36%
Adverse Event
35%
Biopsy Technique
33%
Pancreas Cancer
32%
Immunotherapy
28%
Immunohistochemistry
28%
Gemcitabine
27%
Circulating Tumor Cell
26%
Cancer Cell
25%
Recurrent Disease
24%
Carcinogenesis
24%
Cancer
22%
Esophageal Cancer
22%
Breast Carcinoma
21%
Lung Cancer
21%
Progesterone Receptor
21%
Estrogen Receptor
21%
Pathologist
21%
Pediatrics
20%
Androgen
20%
Urokinase Receptor
20%
Radiosensitization
19%
COVID-19 Vaccine
19%
Sensitization
19%
Tetracosactide
19%
Comorbidity
18%
Mastectomy
18%
Progression Free Survival
18%
Steroid 21 Monooxygenase Deficiency
18%
Checkpoint Kinase 1
18%
Primary Hyperaldosteronism
18%
Spitz Nevus
18%
Quality of Life
18%
Infection
17%
5 (3 Fluorophenyl) N (3 Piperidinyl) 3 Ureido 2 Thiophenecarboxamide
17%
Thorax Surgery
17%
Chemoradiotherapy
16%
Morphology
16%
Hydrocortisone
16%
Radiation Therapy
16%
Homologous Recombination
15%